BIOSINO BIO-TEC (08247) Income Statement & Earnings

2.960
0.0000.00%

Trading May 13 09:00 CST

428.33MMarket Cap-7.57P/E (TTM)

BIOSINO BIO-TEC (08247) Income Statement

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

Turnover

-29.95%184.29M

-28.40%95.82M

-9.00%263.07M

-3.82%133.83M

-22.52%289.07M

-23.61%210.56M

-19.31%139.15M

-19.71%71.1M

7.14%373.07M

5.32%275.66M

Operating income

-29.95%184.29M

-28.40%95.82M

-9.00%263.07M

-3.82%133.83M

-22.52%289.07M

-23.61%210.56M

-19.31%139.15M

-19.71%71.1M

7.14%373.07M

5.32%275.66M

Cost of sales

26.70%-113.37M

22.39%-58.44M

4.35%-154.67M

-3.90%-75.3M

28.70%-161.71M

32.02%-108.67M

29.22%-72.47M

27.31%-39.16M

-10.83%-226.79M

-13.82%-159.85M

Operating expenses

26.70%-113.37M

22.39%-58.44M

4.35%-154.67M

-3.90%-75.3M

28.70%-161.71M

32.02%-108.67M

29.22%-72.47M

27.31%-39.16M

-10.83%-226.79M

-13.82%-159.85M

Gross profit

-34.57%70.92M

-36.14%37.38M

-14.89%108.4M

-12.22%58.53M

-12.93%127.37M

-12.02%101.89M

-4.82%66.68M

-7.91%31.94M

1.87%146.28M

-4.52%115.81M

Selling expenses

20.32%-44.79M

35.72%-20.33M

4.64%-56.21M

-2.99%-31.63M

-7.22%-58.95M

-12.01%-49.5M

-7.90%-30.71M

1.94%-14.49M

-2.15%-54.98M

11.10%-44.19M

Administrative expenses

3.80%-48.48M

-4.42%-23.26M

2.06%-50.39M

13.64%-22.28M

-15.12%-51.45M

-17.58%-38.34M

-20.63%-25.8M

-24.73%-11.92M

-13.29%-44.69M

-4.56%-32.6M

Research and development expenses

19.74%-26.82M

21.03%-13.32M

6.67%-33.42M

-5.75%-16.87M

-33.27%-35.81M

-37.58%-25.68M

-32.75%-15.95M

-72.53%-8.75M

-7.71%-26.87M

-4.40%-18.66M

Impairment and provision

52.12%-9.34M

----

-1,396.70%-19.5M

----

-571.65%-1.3M

----

-50.39%-194K

----

-Other impairment is provision

52.12%-9.34M

----

-1,396.70%-19.5M

----

-571.65%-1.3M

----

-50.39%-194K

----

Special items of operating profit

-281.32%-2.03M

315.99%1.22M

132.77%1.12M

0.68%294K

-358.39%-3.42M

-110.13%-128K

-69.49%292K

-42.98%65K

92.43%-745K

198.83%1.26M

Operating profit

-21.06%-60.54M

-53.25%-18.32M

-112.24%-50.01M

-117.69%-11.95M

-225.33%-23.56M

-154.32%-11.75M

-160.01%-5.49M

-158.54%-3.16M

288.89%18.8M

1.73%21.62M

Financing cost

26.79%-6.81M

-5.92%-4.44M

-45.34%-9.3M

-41.84%-4.19M

6.15%-6.4M

5.01%-4.8M

7.92%-2.95M

-11.40%-1.44M

---6.82M

31.89%-5.05M

Share of profits of associates

144.79%142K

1,460.00%78K

-102.55%-317K

-99.81%5K

88.59%12.41M

151.31%8.47M

113.21%2.66M

38.87%-541K

466.27%6.58M

2,692.31%3.37M

Share of profit from joint venture company

52.53%-47K

-100.00%-18K

-57.14%-99K

68.97%-9K

-36.96%-63K

-50.00%-42K

-61.11%-29K

-88.89%-17K

-111.19%-46K

17.65%-28K

Earning before tax

-12.61%-67.25M

-40.56%-22.69M

-239.07%-59.72M

-177.88%-16.15M

-195.12%-17.61M

-140.76%-8.12M

-181.01%-5.81M

-260.55%-5.15M

189.00%18.52M

45.63%19.91M

Tax

-21.34%2.23M

90.36%-209K

273.89%2.83M

1.45%-2.17M

62.26%-1.63M

-1.85%-2.58M

9.80%-2.2M

7.24%-1.01M

-32.86%-4.31M

-37.47%-2.54M

After-tax profit from continuing operations

-14.30%-65.02M

-25.05%-22.9M

-195.67%-56.89M

-128.61%-18.31M

-235.48%-19.24M

-161.56%-10.7M

-269.29%-8.01M

-391.03%-6.16M

349.43%14.2M

46.90%17.38M

Earning after tax

-14.30%-65.02M

-25.05%-22.9M

-195.67%-56.89M

-128.61%-18.31M

-235.48%-19.24M

-161.56%-10.7M

-269.29%-8.01M

-391.03%-6.16M

349.43%14.2M

46.90%17.38M

Minority profit

3.32%-13.88M

4.01%-4.93M

-89.08%-14.36M

-98.30%-5.13M

-224.56%-7.59M

-177.03%-4.71M

-162.30%-2.59M

-138.05%-1.03M

41.77%6.1M

52.78%6.11M

Profit attributable to shareholders

-20.24%-51.14M

-36.37%-17.98M

-265.14%-42.53M

-143.08%-13.18M

-243.70%-11.65M

-153.18%-5.99M

-1,038.24%-5.42M

-763.97%-5.13M

811.05%8.11M

43.90%11.27M

Basic earnings per share

-20.07%-0.353

-36.26%-0.124

-267.50%-0.294

-145.95%-0.091

-242.86%-0.08

-152.56%-0.041

-1,025.00%-0.037

-300.00%-0.04

800.00%0.056

56.00%0.078

Diluted earnings per share

-20.07%-0.353

-36.26%-0.124

-267.50%-0.294

-145.95%-0.091

-242.86%-0.08

-152.56%-0.041

-1,025.00%-0.037

-300.00%-0.04

800.00%0.056

56.00%0.078

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Lixin Certified Public Accountants (Special General Partnership), Lixin Dehao Certified Public Accountants Limited (Hong Kong)

Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022
Turnover	-29.95%184.29M	-28.40%95.82M	-9.00%263.07M	-3.82%133.83M	-22.52%289.07M	-23.61%210.56M	-19.31%139.15M	-19.71%71.1M	7.14%373.07M	5.32%275.66M
Operating income	-29.95%184.29M	-28.40%95.82M	-9.00%263.07M	-3.82%133.83M	-22.52%289.07M	-23.61%210.56M	-19.31%139.15M	-19.71%71.1M	7.14%373.07M	5.32%275.66M
Cost of sales	26.70%-113.37M	22.39%-58.44M	4.35%-154.67M	-3.90%-75.3M	28.70%-161.71M	32.02%-108.67M	29.22%-72.47M	27.31%-39.16M	-10.83%-226.79M	-13.82%-159.85M
Operating expenses	26.70%-113.37M	22.39%-58.44M	4.35%-154.67M	-3.90%-75.3M	28.70%-161.71M	32.02%-108.67M	29.22%-72.47M	27.31%-39.16M	-10.83%-226.79M	-13.82%-159.85M
Gross profit	-34.57%70.92M	-36.14%37.38M	-14.89%108.4M	-12.22%58.53M	-12.93%127.37M	-12.02%101.89M	-4.82%66.68M	-7.91%31.94M	1.87%146.28M	-4.52%115.81M
Selling expenses	20.32%-44.79M	35.72%-20.33M	4.64%-56.21M	-2.99%-31.63M	-7.22%-58.95M	-12.01%-49.5M	-7.90%-30.71M	1.94%-14.49M	-2.15%-54.98M	11.10%-44.19M
Administrative expenses	3.80%-48.48M	-4.42%-23.26M	2.06%-50.39M	13.64%-22.28M	-15.12%-51.45M	-17.58%-38.34M	-20.63%-25.8M	-24.73%-11.92M	-13.29%-44.69M	-4.56%-32.6M
Research and development expenses	19.74%-26.82M	21.03%-13.32M	6.67%-33.42M	-5.75%-16.87M	-33.27%-35.81M	-37.58%-25.68M	-32.75%-15.95M	-72.53%-8.75M	-7.71%-26.87M	-4.40%-18.66M
Impairment and provision	52.12%-9.34M	----	-1,396.70%-19.5M	----	-571.65%-1.3M	----	----	----	-50.39%-194K	----
-Other impairment is provision	52.12%-9.34M	----	-1,396.70%-19.5M	----	-571.65%-1.3M	----	----	----	-50.39%-194K	----
Special items of operating profit	-281.32%-2.03M	315.99%1.22M	132.77%1.12M	0.68%294K	-358.39%-3.42M	-110.13%-128K	-69.49%292K	-42.98%65K	92.43%-745K	198.83%1.26M
Operating profit	-21.06%-60.54M	-53.25%-18.32M	-112.24%-50.01M	-117.69%-11.95M	-225.33%-23.56M	-154.32%-11.75M	-160.01%-5.49M	-158.54%-3.16M	288.89%18.8M	1.73%21.62M
Financing cost	26.79%-6.81M	-5.92%-4.44M	-45.34%-9.3M	-41.84%-4.19M	6.15%-6.4M	5.01%-4.8M	7.92%-2.95M	-11.40%-1.44M	---6.82M	31.89%-5.05M
Share of profits of associates	144.79%142K	1,460.00%78K	-102.55%-317K	-99.81%5K	88.59%12.41M	151.31%8.47M	113.21%2.66M	38.87%-541K	466.27%6.58M	2,692.31%3.37M
Share of profit from joint venture company	52.53%-47K	-100.00%-18K	-57.14%-99K	68.97%-9K	-36.96%-63K	-50.00%-42K	-61.11%-29K	-88.89%-17K	-111.19%-46K	17.65%-28K
Earning before tax	-12.61%-67.25M	-40.56%-22.69M	-239.07%-59.72M	-177.88%-16.15M	-195.12%-17.61M	-140.76%-8.12M	-181.01%-5.81M	-260.55%-5.15M	189.00%18.52M	45.63%19.91M
Tax	-21.34%2.23M	90.36%-209K	273.89%2.83M	1.45%-2.17M	62.26%-1.63M	-1.85%-2.58M	9.80%-2.2M	7.24%-1.01M	-32.86%-4.31M	-37.47%-2.54M
After-tax profit from continuing operations	-14.30%-65.02M	-25.05%-22.9M	-195.67%-56.89M	-128.61%-18.31M	-235.48%-19.24M	-161.56%-10.7M	-269.29%-8.01M	-391.03%-6.16M	349.43%14.2M	46.90%17.38M
Earning after tax	-14.30%-65.02M	-25.05%-22.9M	-195.67%-56.89M	-128.61%-18.31M	-235.48%-19.24M	-161.56%-10.7M	-269.29%-8.01M	-391.03%-6.16M	349.43%14.2M	46.90%17.38M
Minority profit	3.32%-13.88M	4.01%-4.93M	-89.08%-14.36M	-98.30%-5.13M	-224.56%-7.59M	-177.03%-4.71M	-162.30%-2.59M	-138.05%-1.03M	41.77%6.1M	52.78%6.11M
Profit attributable to shareholders	-20.24%-51.14M	-36.37%-17.98M	-265.14%-42.53M	-143.08%-13.18M	-243.70%-11.65M	-153.18%-5.99M	-1,038.24%-5.42M	-763.97%-5.13M	811.05%8.11M	43.90%11.27M
Basic earnings per share	-20.07%-0.353	-36.26%-0.124	-267.50%-0.294	-145.95%-0.091	-242.86%-0.08	-152.56%-0.041	-1,025.00%-0.037	-300.00%-0.04	800.00%0.056	56.00%0.078
Diluted earnings per share	-20.07%-0.353	-36.26%-0.124	-267.50%-0.294	-145.95%-0.091	-242.86%-0.08	-152.56%-0.041	-1,025.00%-0.037	-300.00%-0.04	800.00%0.056	56.00%0.078
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--
Auditor	Lixin Certified Public Accountants (Special General Partnership), Lixin Dehao Certified Public Accountants Limited (Hong Kong)	--	Lixin Certified Public Accountants (Special General Partnership), Lixin Dehao Certified Public Accountants Limited (Hong Kong)	--	Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young	--	--	--	Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"